September 28, 2023
(press release)
–
Accrol Group Holdings plc, the UK's leading independent tissue converter, announces that its Annual Report for the year ended 30 April 2023, together with the Notice of its 2023 Annual General Meeting (AGM) are now available on the Group's website https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/ Copies of both documents will also be distributed to shareholders later today. The AGM is to be held at the Group's registered office at Delta Building, Roman Road, Blackburn BB1 2LD at 11:00am on 24 October 2023. For further information, please contact: Accrol Group Holdings plc Dan Wright, Executive Chairman Via Belvedere Communications Gareth Jenkins, Chief Executive Officer Chris Welsh, Chief Financial Officer Zeus (Nominated Adviser & Broker) Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512 Dominic King Tel: +44 (0) 203 829 5000 Shore Capital Stockbrokers (Joint Broker) Tel: +44 (0) 20 7408 4090 Malachy McEntyre/ Mark Percy / James Thomas Isobel Jones Belvedere Communications Limited Cat Valentine Tel: +44 (0) 7715 769 078 Keeley Clarke Tel: +44 (0) 7967 816 525 Overview of Accrol Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value. For more information, please visit www.accrol.co.uk. Link for Accrol Today video: https://www.accrol.co.uk/our-business/ This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
